Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Inclusion Criteria: * 1\. Is a male or female subject between the ages of 12 and 65 years, inclusive. * 2\. Asthma that has been stable for at least four weeks prior to screening as defined by clinical history. * 3\. Reversible bronchoconstriction. * 4\. Has body weight more than 30 kilogram (kg) and body mass index between 18 and 34 kg/m², inclusive. * 5\. Has no medical history of hypertension and cardiovascular disease in the last 10 years. * 6\. At screening, has stable vital signs. Exclusion Criteria: * 1\. History of clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic, endocrine, oncologic, pulmonary, immunologic, psychiatric, or cardiovascular disease or any other condition. * 2\. Patients receiving beta blocker. * 3\. Has any clinically significant medical condition or physical exam finding as deemed inappropriate by the Investigator. * 4\. Has abnormal cardiovascular exam at screening including any prior history of myocardial infarction or clinically significant abnormal electrocardiogram. * 5\. Has mucosal inflammatory disorders. * 6\. Has had significant traumatic injury, major surgery or open biopsy within 30 days prior to study screening.